Hugo, Feona .

HRN: 22-63-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/13/2023
12/19/2023
IVT
300mg
Q6
Acute Tonsillopharyngitis Urti
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTIEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: